Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus.
| Autor: | Boedecker-Lips, Simone Cosima, Claßen, Paul, Kraus, Daniel, Weinmann-Menke, Julia |
|---|---|
| Předmět: |
VACCINES
COVID-19 IMMUNIZATION IMMUNOGLOBULINS COVID-19 vaccines CORONAVIRUS spike protein CHEMILUMINESCENCE assay IMMUNOSUPPRESSION TREATMENT effectiveness SEVERITY of illness index IMMUNOASSAY MESSENGER RNA DRUG interactions SYSTEMIC lupus erythematosus VIRAL antibodies BELIMUMAB MEDICAL research PHARMACODYNAMICS |
| Zdroj: | Rheumatology; Mar2023, Vol. 62 Issue 3, pe34-e35, 2p |
| Abstrakt: | The article presents a study which examined whether belimumab is associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus (SLE). Topics discussed include information on SLE, patient characteristics and treatment details, and the need to closely observe lupus patients with SARS-CoV-2 infection and to be wary of the possibility of severe illness. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|